STAT podcast examines gene-editing IP dispute and public trust in science

The latest episode of STAT's 'The Readout LOUD' covers the Beam Therapeutics intellectual-property lawsuit and broader questions about why public confidence in science has declined.

Published · AI-drafted summary based on 1 public source
Illustration for crispr story
Illustrative image — not from the source article.
Share

STAT News's podcast 'The Readout LOUD' addressed two themes in its 1 October 2026 episode: the intellectual-property lawsuit involving Beam Therapeutics — which has filed suit against a former scientist and a Chinese biotechnology company over alleged base-editing trade-secret theft — and the question of declining public trust in science more broadly.

The IP litigation thread picks up reporting covered in a separate Genetic Current cluster on 30 September 2026. The trust-in-science segment reflects an ongoing editorial focus at STAT on how the pandemic, misinformation, and political polarisation have affected public confidence in biomedical research institutions.

Neither thread involves new primary research findings. The episode is of relevance to researchers and science communicators interested in the policy and social dimensions of the gene-editing field, and to educators looking for current examples of how intellectual-property disputes arise in genome-editing biotechnology. The full podcast is freely accessible.

Sources

Read the original reporting — these are the public sources this summary draws from.

  1. Primary source Stat News · 2026-10-01
    Mistrust in science and a juicy gene-editing lawsuit

Tags

gene-editing intellectual-property beam-therapeutics trust-in-science science-communication biotech-industry
Share

About Genetic Current

Educational summaries of public genetics news

Genetic Current is the news section of Evagene, an academic, research, and educational pedigree-modelling platform. Stories are AI-drafted summaries of items from trusted public sources, written for researchers, clinicians, educators, students, genealogists, and patients with an interest in genetics. Summaries are for educational and research purposes only and are not medical advice.

Join the Evagene Alpha Waiting List